We also found trends to significance for variants rs2234167 of TNFRSF14, rs35041805 of TNFRSF19, and rs1046668 of TNFAIP6, with higher frequencies for patients with MS than for individuals without the disease. This evidence concerns the gene TNFRSF19 and myeloid sarcoma.